NCT06861062View on ClinicalTrials.gov

Effects of Vitamin D3 and Yeast Beta-Glucan Supplementation on Cardiovascular Disease in Patients With Type 2 Diabetes

NARecruitingINTERVENTIONAL
Enrollment

8,000

Participants

Timeline

Start Date

April 8, 2025

Primary Completion Date

December 31, 2030

Study Completion Date

December 31, 2032

Conditions
Diabetes Mellitus, Type 2
Interventions
DRUG

Vitamin D3

Vitamin D3(cholecalciferol),1600 IU per day.

DIETARY_SUPPLEMENT

yeast β-glucan

yeast β-glucan, 600mg per day.

DIETARY_SUPPLEMENT

Vitamin D placebo

Vitamin D placebo

DIETARY_SUPPLEMENT

yeast β-glucan placebo

yeast β-glucan placebo

Trial Locations (5)

430000

RECRUITING

Huazhong University of Science and Technology, Wuhan

Unknown

RECRUITING

Guangxi Medical College, Nanning

RECRUITING

Kailuan General Hospital, Tangshan

RECRUITING

Sinopharm Dongfeng General Hospital, Shiyan

RECRUITING

Sichuan University, Chengdu

All Listed Sponsors
lead

Huazhong University of Science and Technology

OTHER